Bioinformatics Keep it Small, Stupid | GenomeWeb

One thing Ilya Mazo, co-founder and acting president of bioinformatics startup Ariadne Genomics, learned from his three years at InforMax is that size matters. “If you want to be successful in this area, you have to stay small,” he says. In fact if InforMax had realized its dream of becoming a large, dominating, successful corporation, Ariadne would probably not exist: Its four co-founders, Mazo along with Alexander Nikitin, Sergei Egorov, and Nikolai Daraselia, are all refugees from InforMax’s downfall. The lesson?

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.